Faculty who have authored publication Efficacy and safety of guselkumab, an anti-interleukin-23 monoclonal antibody, compared with adalimumab for the treatment of patients with moderate to severe psoriasis with randomized withdrawal and retreatment: Results from the phase III, double-blind, placebo- and active comparator-controlled VOYAGE 2 trial.
| Name | Title | Department | Institution |
|---|---|---|---|
| Kenneth Brian Gordon MD | Chair, Professor | Dermatology | Medical College of Wisconsin |
